NELLY TAN, MD
Radiology in Los Angeles, CA

License number
California A114724
Category
Radiology
Type
Diagnostic Radiology
Address
Address
757 Westood Plz, Los Angeles, CA 90095
Phone
(310) 957-9021
(310) 267-8758

Personal information

See more information about NELLY TAN at radaris.com
Name
Address
Phone
Nelly Tan
12903 La Barranca Rd, Los Altos, CA 94022
(408) 910-1918
Nelly Tan
2218 38Th Ave, San Francisco, CA 94116
(415) 665-2838
Nelly Tan
243 Harbor Beach Ct, Santa Cruz, CA 95062
(858) 240-7571
Nelly Tan, age 73
2466 24Th Ave, San Francisco, CA 94116
Nelly Tan
Oceanside, CA
(760) 721-0343

Organization information

See more information about NELLY TAN at bizstanding.com

Nelly Tan MD

757 Westwood Plz #2129, Los Angeles, CA 90095

Categories:
Radiology Physicians & Surgeons
Phone:
(310) 825-1380 (Phone)

Professional information

Nelly Tan Photo 1

Dr. Nelly Tan, Los Angeles CA - MD (Doctor of Medicine)

Specialties:
Diagnostic Radiology
Age:
41
Address:
UNIVERSITY OF CALIFORNIA LOS ANGELES
757 Westwood Plz, Los Angeles 90095
(310) 825-6301 (Phone)
Languages:
English
Education:
Medical School
University of California At Los Angeles
Graduated: 2007


Nelly Tan Photo 2

Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-Met Signaling

US Patent:
2011019, Aug 4, 2011
Filed:
Mar 31, 2009
Appl. No.:
12/935643
Inventors:
Donald P. Bottaro - Kensington MD, US
Megan Peach - Ashburn VA, US
Marc Nicklaus - Catonsville MD, US
Terrence Burke, JR. - Bethesda MD, US
Gagani Athauda - Southwest Ranches FL, US
Sarah Choyke - Rockville MD, US
Alessio Giubellino - Washington DC, US
Nelly Tan - Los Angeles CA, US
Assignee:
The Govt of the U.S.A., as rep.by the Sec.Dept of Hlth. and Human Svcs., Natl Institutes of Health - Rockville MD
International Classification:
A61K 31/5377, C07D 213/85, A61K 31/44, C07D 413/12, C07D 239/02, A61K 31/505, A61P 35/00
US Classification:
5142355, 546288, 514344, 544131, 544311, 514269
Abstract:
Derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, pharmaceutical compositions containing derivatives and analogs of c-Met inhibitors are provided. Methods of making derivatives and analogs of c-Met inhibitors and methods of use thereof are provided.